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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A137Conclusions: These data showed that xenosestrogens as well as the
vinclozolin metabolite M2 modiﬁed the rate of early chondrogenic
differentiation by transiently maintaining COL2A expression. Our
hypothesis is that COL2A induced persistence, might provoke matrix
weakening in the long term and/or sequester growth factors, eventually
modifying the course of cartilage degenerative diseases such as osteo-
arthritis. EDC also modiﬁed COL2A expression in dedifferentiated
chondrocytes such as found in aging or osteoarthritic tissues. These data
are in accordance with the strong Col2A expression reported in OA
cartilage but its role remains to be studied.
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QUANTITATIVE PROTEOMICS OF ARTICULAR CARTILAGE USING
SEQUENTIAL EXTRACTION OF TRANSVERSE CRYOSECTIONS
M.-F. Hsueh y, V.B. Kraus z, A. Khabut x, P. €Onnerfjord x. yDept. of
Pathlogy, Duke Univ., Durham, NC, USA; zDept. of Med., Duke Univ.,
Durham, NC, USA; xDept. of Clinical Sci., Lund Univ., Lund, Sweden
Purpose: Articular cartilage is a highly cross-linked tissue. Because the
insoluble collagen-rich residues are left behind after commonly used
guanidine-HCl (Gu-HCl) extraction, the composition of the insoluble
residue has not been fully elucidated. Moreover, articular cartilage has a
variety of microenvironments varying by distance from the surface
(superﬁcial, middle, and deep layers) or distance from the chondrocyte
(pericellular, territorial and interterritorial zones). We hypothesize that
during joint damage, the catabolic activities and the rate of protein
synthesis vary between these subregions. The goal of this study was to
quantify the amount of extractable and non-extractable protein and to
elucidate the differences between subregions in different joints (hip
and knee) and under different physiological conditions (healthy and
osteoarthritis).
Methods: We collected hip and knee cartilage samples (healthy and
osteoarthritic) as surgical waste from surgical repair of trauma or joint
replacement. Transverse cryosections were generated by distance from
the surface. To avoid the confounding background by intracellular
proteins, chondrocytes were depleted by performing one rapid freeze/
thaw cycle in hypotonic solution. We performed Gu-HCl extraction to
obtain extractable proteins from knee cartilage sections and in situ
trypsin digestion to extract proteins from the insoluble residue. An
adjacent set of cartilage sections from knee and hip cartilage were
acquired for toluidine blue staining to distinguish different zones. By
laser capture microscopy (LCM, Carl Zeiss PALM Microbeam), we pre-
cisely sampled (~2 mm2 area samples) the cartilage matrix from the
territorial (T) and interterritorial (IT) matrix zones from each layer. We
performed in situ trypsin digestion of these LCM-harvested samples to
extract all proteins including portions of the insoluble residue
remaining after Gu-HCl extraction. All batches of extracts were quan-
tiﬁed using multiple reaction monitoring (MRM) by a triple quadropole
instrument (TSQ-Vantage, Thermo). We calculated the ratio of
extractable to total protein (sum of extractable and non-extractable)
and deﬁned this value as extractability.
Results: As expected, aggrecan core protein was readily extracted by
Gu-HCl methods. It was noteworthy that the extractability of cartilage
intermediate layer protein (CILP) 1-1 increased with cartilage depth in
arthritic cartilage, but decreased in healthy cartilage. However, the
extractability of CILP 1-2 increased with cartilage depth in both types of
cartilage. In arthritic cartilage, a signiﬁcant increase of extractability
was identiﬁed in several proteins, including ﬁbronectin (FINC) and
cartilage acidic protein 1 (CRAC1). We also investigated the protein
distribution in distinct and precisely sampled subregions of cartilage.
Similar to previous work focused on aggrecan core protein, the amount
of all three aggrecan subdomains increased in the deeper regions. The
aggrecan G3 domain accumulated in the territorial regions while the G1
and G2 domains accumulated in the interterritorial regions. These
patterns were the same in both healthy knee and hip cartilage.
Conclusions: Characterization of the precise cartilage matrix archi-
tecture by subregions can provide insights into protein networks and
signaling as well a reﬁned understanding of the catabolic and anabolic
responses to arthritis. Interestingly, the extractability by Gu-HCl of
some matrix proteins was increased in arthritic cartilage suggesting
either increased amounts of protein and/or altered protein interactions
to make them more readily dissociated from the cartilage meshwork.
Our LCM experimental system coupled with modern proteomic tool
was validated by the comparability of our results for aggrecan domains
by subregion with what is known in the literature. Ongoing analysis ofother targeted proteins will be expected to provide a compelling new
and comprehensive understanding of their distributionwithin cartilage
and a global understanding of matrix architecture in health and disease.
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IMPAIRED LONG BONE GROWTH IN CHONDROCYTE-SPECIFIC ERP57
KNOCKOUT MICE IS INDUCED BY ER STRESS
A. Linz y, Y. Knieper y, T. Gronau z, A. Aszodi x, N. Garbi 4,
G.J. H€ammerling ¶, T. Pap#, P. Bruckner y, R. Dreier y. yWestfalian
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Münster, Germany; zUniv. Hosp. Münster, Inst. of Experimental
Musculoskeletal Med. (IEMM), Münster, Germany; x Experimental
Surgery and Regenerative Med., Dept. of Surgery, Ludwig-Maximilians-
Univ., München, Germany; kUniv. of Bonn, Dept. of Molecular
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Purpose: During long bone growth by endochondral ossiﬁcation
chondrocytes produce large amounts of extracellular matrix macro-
molecules. Before folding and entering the secretory pathway, these
molecules are subject to extensive post-translational modiﬁcation,
orchestrated by chaperone complexes in the endoplasmic reticulum
(ER). ERp57 is a member of the protein disulﬁde isomerase (PDI) family
and facilitates correct folding of newly synthesized glycoproteins by
rearrangement of native disulﬁde bonds. Here, we analyzed the func-
tional role of ERp57 in bone development and growth in vivo.
Methods: Cartilage speciﬁc ERp57 knockout (KO) mice were generated
by mating ERp57 ﬂx/ﬂx mice with mice expressing alpha1 Collagen II-
driven cre-recombinase. Size, weight, and bone length was determined
in KO and wild type (WT) littermates at post-natal days 1, 7, 12 and at 1
and 2 months. Parafﬁn-embedded legs were analyzed by extensive
histological, immunohistological and TUNEL staining. Tibiae of 1 month
old mice were investigated by micro-computed tomography.
Results: The mice were viable, had a normal lifespan, and were fertile.
However, their post-natal weight gain and growth of long bones was
retarded, suggesting that ERp57 function is required for normal skeletal
development and growth. The differences between KO and WT animals
in male mice were maximal at the time of their pubertal growth spurt.
Loss of ERp57 triggered ER stress, unfolded protein response, reduced
proliferation and accelerated apoptotic cell death of chondrocytes.
Together this resulted in a delay of long bone growth with the following
characteristics: 1. enlarged growth plates; 2. expanded hypertrophic
zones; 3. retarded osteoclast recruitment; 4. delayed remodeling of the
proteoglycan-rich matrix and 5. delayed formation of trabecular bone in
the primary and secondary ossiﬁcation centers. All the growth plate
abnormalities, however, became attenuated after the pubertal growth
spurt, when protein synthesis is decelerated and, hence, ERp57 chap-
erone function is less essential.
Conclusions: ERp57-dependent protein disulﬁde isomerase activity is
crucial for skeletal development and growth. Loss of ERp57 chaperone
function results in ER stress and delays bone growth especially during
the pubertal growth spurt when matrix deposition is particularly
intensive.
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TGF-BETA BLOCKS CHONDROCYTE HYPERTROPHY AND MAINTAINS
CELL VIABILITY IN CULTURED CARTILAGE EXPLANTS BUT DOES
NOT PROTECT AGAINST PROTEOGLYCAN LOSS
A.P. van Caam, W. Madej, H.M. van Beuningen, E.N. Blaney Davidson,
P.M. van der Kraan. Radboud Univ. Med. Center, Nijmegen, Netherlands
Purpose: Degradation of the extracellular matrix of cartilage is a key
aspect of osteoarthritis. In part, this degradation is due to chondrocytes
gaining a hypertrophy-like phenotype, characterized by increased
production of matrix metalloproteinase 13 (Mmp13) and collagen type
X (Col10a1). TGFb1 is considered to be a protective factor for articular
cartilage. It is able to block hypertrophy and able tomaintain or increase
production of glycosaminoglycans (GAG), an essential matrix compo-
nent. These functions of TGFb1 havemainly been identiﬁed using either
stem cells or very young cartilage. However, TGFb1-signaling is differ-
ent in mature cartilage compared to young cartilage. Therefore, we
investigated the effect of TGFb1-signaling on healthy mature cartilage
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A138in regard of chondrocyte phenotype, viability and total amount of GAGs
in long term ex-vivo culture.
Methods: Bovine articular cartilage explants were isolated from the
metacarpophalangeal joint of healthy 5 yr old adult cowswithin 3 h post
mortem. Subsequently, explants were cultured in DMEM/F12 alone or
supplemented with either 10% Fetal Calf Serum (FCS), rhTGFb1 or
Insulin-like growth factor 1 (rhIGF1) for the duration of 2 weeks.
Medium was refreshed every 72 h. To investigate via which TGFb1
receptor, ALK1 or ALK5, the observed TGFb1 effects run, the ALK5-
kinase inhibitor SB-505124 was used at a concentration of 5 mM. In
these experiments, DMSO was used as vehicle control. Sulfated-glyco-
saminoglycans (GAGs) were measured using dimethylmethylene blue
(DMB) (Farndale assay). Cellular viability was measured with the use of
XTT. To correct for the amount of cells, total DNA content of explants
was measured using PicoGreen. Furthermore, gene expression of
chondrocyte hypertrophy markers was measured using qPCR with
validated, cDNA-speciﬁc, primers.
Results: Comparedto freshly isolated samples, expression of the chon-
drocyte-hypertrophy markers Col10a1 and Mmp13 was profoundly
upregulated 64-fold in explants cultured for 2 weeks ex vivo and Sox9
expression was decreased 2-fold. The addition of 10% FCS to the
medium did not inhibit the upregulation of these genes, and even
induced expression of Alkaline phosphatase (Alpl), another marker of
chondrocyte hypertrophy. In contrast, addition of TGFb1 (1 ng/ml or 10
ng/ml) almost fully blocked induction of Col10a1 and Mmp13 expres-
sion, and lowered expression of Alpl 4-fold. Additionally, TGFb1 induced
Col2a1 expression 16-fold. Furthermore, TGFb1 also maintained chon-
drocyte viability, because after 2weeks mitochondrial activity corrected
for DNA content was 50% higher in TGFb1 treated samples compared to
10% FCS. All these effects of TGFb1 were blocked by 5 mM of the ALK5-
kinase inhibitor SB-505124. Apart from induction of chondrocyte
hypertrophy marker genes, long term ex vivo explant culture also
resulted in GAG loss; total GAG content was reduced from approx-
imately 4 % of wet weight in freshly isolated tissue to 1% of wet weight
in the course of 2 weeks. As expected, addition of 10% FCS fully pre-
vented GAG loss over time. However, addition of TGFb1 to the medium
remarkably did not inhibit GAG loss over time. Replacement of 10% FCS
with 20 ng/ml of IGF1 also prevented GAG loss, but surprisingly, when
IGF1 was combined with TGFb1, TGFb1 inhibited the positive effect of
IGF1 on total GAG content.
Conclusions: Based on our results, we conclude that in adult cartilage
TGFb1 is a potent inhibitor of chondrocyte hypertrophy and that this
inhibition runs via ALK5. Additionally, TGFb1 profoundly induced
Col2a1 production, and maintained chondrocyte viability in long term
culture. In contrast, TGFb1 was not able to counteract GAG depletion
over time and even inhibited the beneﬁcial effect of IGF1 on total GAG-
content in cartilage, demonstrating that TGFb1 does not positively
regulate GAG content in adult cartilage directly.
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DIFFERENTIAL REGULATION OF AUTOPHAGY IN ARTICULAR
CARTILAGE CHONDROCYTES AND SYNOVIAL FIBROBLASTS DURING
OSTEOARTHRITIS
Y. Zhang, A. Weston, K. Perry, R. Gandhi, N. Mahomed, J.-P. Pelletier,
J. Martel-Pelletier, M. Kapoor. Toronto Western Hosp./Univ. of Toronto,
Toronto, ON, Canada
Purpose: Osteoarthritis (OA) is the most common form of arthritis. Two
major joint structures that typically play a key role in the initiation and
progression of OA include articular cartilage and synovium. Chon-
drocytes are the only cell types present in the articular cartilage. During
OA episode, chondrocytes have the ability to undergo accelerated cell
death. Contrastingly, synovial ﬁbroblasts exhibit opposite proliferative
and replication phenotype than chondrocytes. During OA, synovial
ﬁbroblasts tend to proliferate faster and exhibit higher rate of cell sur-
vival. Understanding the exact cell death and survival mechanisms in
chondrocytes and synovial ﬁbroblasts within the joint structure is
essential to devise strategies to achieve joint homeostasis. We have
previously shown that process of autophagy, a cell survival mechanism,
is signiﬁcantly compromised in the articular chondrocytes during OA
resulting in enhanced chondrocyte apoptosis and increased catabolicactivity leading to degeneration of the articular cartilage, we inves-
tigated the expression and regulation of autophagy markers in OA
synovial ﬁbroblasts.
Methods: Normal and human synovial ﬁbroblasts were cultured and
subjected to qPCR and western blot analysis to determine the expres-
sion of autophagy markers in human OA ﬁbroblasts compared to nor-
mal ﬁbroblasts.
Results: Our results showed that synovial ﬁbroblasts exhibit opposite
autophagy regulation and activity compared to chondrocytes during
OA. Speciﬁcally, we observed a signiﬁcant up-regulation in the
expression of critical autophagosome and autophagy activity markers
including LC3B, ULK1, AMPK1, and ATG3 in synovial ﬁbroblasts from OA
patients compared to healthy controls. Further, we determined the
expression of TGF-b, major proﬁbrotic factor involved in ﬁbroblast
survival and proliferation. Compared to healthy control ﬁbroblasts, OA
ﬁbroblasts exhibit increased expression of TGF-b1 and phosphorylation
of its downstream SMAD2/3 signalling pathway. Treatment with TGF-
b1 resulted in increased expression of both LC3B and ULK1 that corre-
lated with increased rate of cell proliferation.
Conclusions: These results show that two joint structures (articular
cartilage and synovium) exhibit differential autophagy regulation dur-
ing OA: (a) Loss of autophagy in articular chondrocytes results in
accelerated chondrocyte cell death. (b) Increased autophagy results in
enhanced synovial ﬁbroblast survival and proliferation. We now plan to
investigate the regulation of autophagy in subchondral bone in OA.
Understanding the exact autophagy mechanisms and associated cell
survival mechanisms will help us understand joint homeostasis and
delay or stop the progression of OA.
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LOOSE BODIES IN THE KNEE JOINT e A RECAPITULATION OF
ENDOCHONDRAL OSSIFICATION
J. Bertrand y, T. Gronau y, I. Leifert y, T. Pap y, W. Rüther z. y Inst. for
Experimental Musculoskeletal Med., Münster, Germany; zDept. of
Orthopaedics, Univ. Med. Ctr. Hamburg-Eppendorf, Hamburg, Germany
Purpose: Loose bodies are free ﬂoating elements of bone and cartilage
in the knee or any joint affected. Loose bodies can be caused by
degenerative joint disease, a bone fragment resulting from fracture or
possibly a torn piece of cartilage. They can cause symptoms such as:
pain and swelling, the inability to straighten the knee, intermittent
locking of the knee. The hypothesis of the study was that loose bodies
develop via endochondral ossiﬁcation.
Methods: Loose bodies were harvested during surgery. They were ﬁxed
in 4% PFA over night and embedded in parafﬁn. Bone architecture was
analysed using X-Ray and mCT analysis. For analysis of histological
composition sections were stained using safranin-orange and alizarin-
red/ alcian blue staining. Immunohistological stainings for collagen II,
collagen VI, collagen X and MMP13 were performed. Osteoclasts were
detected using TRAP staining and osteoblasts using osterix.
Results: X-Ray and mCT analyses revealed a trabecular structure in some
of these bodies. We found 4 stages of loose body differentiation: a
ﬁbrous, a cartilage, a bone/ cartilage and a bone stage. We found that a
synovium like tissue surrounds stages 1-3, but is not present any more
at the bone stage. All stages aremarked by expression of speciﬁc marker
proteins. Stage 1 expresses high levels of collagen II, no collagen X and
MMP13. Only a weak staining for collagen VI is present, indicating
nearly no hyaline cartilage. Stage 2 expresses high levels of collagen II,
VI as well as X and MMP13. These staining indicate that the loose body
is formed mainly of hyaline cartilage, which chondrocytes differ-
entiating to hypertrophic state. Stage 3 also expresses all collagens,
showing increased amounts of MMP13 and collagen X. Furthermore,
osterix positive cells can be found indicating a differentiation to an
osteoblastic phenotype. Stage 4 expresses only at the superﬁcial layer
collagen II, nearly no collagen X and VI, as well as MMP13. Some osterix
positive cells can be found. No osteoclasts were found in all stages.
Conclusions: Loose bodies seem to derive from a cartilage like source
and then undergo endochondral ossiﬁcation. A transdifferentiation into
a more ﬁbroblast like phenotype, as well as an osteoblast like pheno-
type can be observed. The differentiation to osteoclasts, however, seems
not to be possible.
